Stocks
Heron Therapeutics (HRTX) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -215.3 | -176.7 | -103.8 | -5.06 | -17.9 | -20.6 | ||
| Changes by years, y/y, % | -3% | -18% | -41% | -95% | +254% | -39.6% | |||
Heron Therapeutics. EBITDA US GAAP, bln rub
Heron Therapeutics. EBITDA US GAAP, changes, %
Heron Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Heron Therapeutics (HRTX) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 3.71 | -1.77 | -14.0 | -0.792 | -8.11 | -20.6 | |
| Changes by years, y/y, % | -190% | -70% | +261% | -109% | -319% | |||
| Changes by quarters, q/q, % | -58% | -148% | +690% | -94% | +924% | |||
